“COST-UTILITY ANALYSIS OF FENOFIBRATE IN SLOWING PROGRESSION OF DIABETIC RETINOPATHY IN VIETNAM”, YHCĐ, vol. 67, no. CĐ11-NCKH, Aug. 2026, doi: 10.52163/yhc.v67iCD11.6071.